COVID-19不同时期防控措施对NSTEMI住院患者并发肺部感染的诊断和预后影响

doi:10.3969/j.issn.1671-7171.2021.12.002

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1124 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要【目的】分析新型冠状病毒肺炎(COVID-19)不同时期防控措施对非ST段抬高型心肌梗死(NSTEMI)住院患者并发肺部感染的诊断和预后影响。【方法】回顾性分析苏州大学附属第三医院在COVID-19不同防控措施下收治的126例NSTEMI患者,分为非新冠疫情流行组(2019年1月25日至2019年2月25日,非流行组,n=47),新冠疫情一级响应组(2020年1月25日至2020年2月25日,一级响应组,n=42)和新冠疫情常态化防控组(2021年1月25日至2021年2月25日,常态防控组,n=37)。比较三组研究对象的临床特征、肺部感染以及院内病死率,分析疫情防控措施下NSTEMI住院患者并发肺部感染的影响因素。【结果】三组患者就诊时间、卧床时间、心率和心力衰竭比较,差异有统计学意义(P<0.05)。非流行组、一级响应组和常态防控组肺部感染发生率比较差异有统计学意义(P<0.01)。多因素二元Logistic回归分析显示,就诊时间、心力衰竭和卧床时间是NSTEMI患者发生肺部感染的影响因素(均P<0.05)。【结论】COVID-19防控一级响应期间的救治措施提高了NSTEMI患者中肺部感染的诊断率,但未增加NSTEMI并发肺部感染患者院内不良预后。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

关键词 ：非ST段抬高型心肌梗死/并发症, 肺炎/诊断, 冠状病毒感染/预防和控制, 预后

Abstract：【Objective】To analyze the diagnosis and prognosis of pulmonary infection in patients with non ST segment elevation myocardial infarction (NSTEMI) at different stages of New Coronavirus pneumonia (COVID-19). 【Methods】A retrospective analysis of 126 NSTEMI patients admitted to the Third Affiliated Hospital of Suzhou University under different prevention and control measures of COVID-19 was made into non COVID-19 epidemic group. (January 25, 2019 to February 25, 2019, non epidemic group, n=47), COVID-19 first responder group (January 25, 2020 to February 25, 2020, first responder group, n=42) and COVID-19 normal control group. (from January 25, 2021 to February 25, 2021, normal control group, n=37). The clinical characteristics, pulmonary infection and hospital mortality of the three groups were compared, and the influencing factors of NSTEMI inpatients complicated with pulmonary infection under epidemic prevention and control measures were analyzed. 【Results】 There were significant differences in visit time, bed time, heart rate and heart failure among the three groups (P<0.05). There was significant difference in the incidence of pulmonary infection among non epidemic group, primary response group and normal prevention and control group (P<0.001). Multivariate binary logistic regression analysis showed that visit time, heart failure and bed time were the influencing factors of pulmonary infection in NSTEMI patients (mean P<0.05). 【Conclusion】 The treatment measures during the first-class response of covid-19 prevention and control improved the detection rate of pulmonary infection in patients with NSTEMI, and did not increase the adverse prognosis in hospital in patients with NSTEMI complicated with pulmonary infection.

Key words： Non-ST Elevated Myocardial Infarction/CO Pneumonia/DI Coronavirus Infections/PC Prognosis

收稿日期: 2021-06-07

中图分类号:

R542.22

基金资助:江苏省医学创新团队(CXTDC2016013)

通讯作者: **E-mail:susanmine8786@163.com

引用本文:

王强, 杨承健, 张晓璞, 杨玲, 苏彤. COVID-19不同时期防控措施对NSTEMI住院患者并发肺部感染的诊断和预后影响[J]. 医学临床研究, 2021, 38(12): 1764-1766.
WANG Qiang, YANG Cheng-jian, ZHANG Xiao-pu, et al. Effects of Covid-19 Prevention and Control Measures in Different Periods on the Diagnosis and Prognosis of NSTEMI Inpatients Complicated with Pulmonary Infection. JOURNAL OF CLINICAL RESEARCH, 2021, 38(12): 1764-1766.

链接本文:

http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2021.12.002 或 http://journal07.magtech.org.cn/yxlcyj/CN/Y2021/V38/I12/1764

[1] MCMANUS D D. Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI[J].Am J Med,2011, 124(1):40-47.
[2] KRAHN C L, RAFFIN R P, SANTOS G S, et al. Isoflurane-loaded nanoemulsion prepared by high-pressure homogenization: investigation of stability and dose reduction in general anesthesia [J].J Biomed Nanotechnol,2012, 8(5):849-858.
[3] XIONG T Y, REDWOOD S, PRENDERGAST B, et al. Coronaviruses and the cardiovascular system: acute and long-term implications [J].Eur Heart J,2020, 41(19):1798-1800.
[4] 中华医学会心血管病学分会. 新型冠状病毒肺炎疫情防控期间心血管急危重症患者临床处理原则的专家共识[J].中华心血管病杂志,2020,48(3):189-194.
[5] ROFFI M, PATRONO C, COLLET J P, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC) [J].Eur Heart J,2016, 37(3):267-315.
[6] 蔡柏蔷, 李龙芸. 《协和呼吸病学》[M]. 第2版. 北京:中国协和医科大学出版社, 2011:231-240.
[7] 汪蛟龙,李枫,宁伟.急性心肌梗死患者血脂水平变化与PCI术后并发症及预后的相关性分析[J].医学临床研究,2019,36(4):710-712.
[8] MUSHER D M, ABERS M S, CORRALES-MEDINA V F. Acute Infection and Myocardial Infarction [J].N Engl J Med,2019, 380(2):171-176.
[9] CANGEMI R, CASCIARO M, ROSSI E, et al. Platelet activation is associated with myocardial infarction in patients with pneumonia [J].J Am Coll Cardiol,2014, 64(18):1917-1925.
[10] REN S, NEWBY D, LI S C, et al. Effect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysis [J].Open Heart,2015, 2(1):e000247.
[11] BOOKER S, MURFF S, KITKO L, et al. Mouth care to reduce ventilator-associated pneumonia [J].Am J Nurs,2013, 113(10):24-30.